Total Funding
6
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
Amarantus BioSciences develops treatments for diseases associated with the dysfunction of biological pathways.
Gerald E. Commissiong: President & CEO, DirectorPast Role: Amarantus BioSciences, COO
About the Company
Amarantus BioSciences is a development-stage, publicly-traded biotechnology company discovering and developing first-in-class treatments for diseases associated with the dysfunction of a wide range of biological pathways, beginning with apoptosis. The company focuses on developing therapeutic products for orphan drug designation in the areas of
neurology, psychiatry, ophthalmology, and regenerative medicine, and diagnostics in neurology. its prime therapeutic program, eltoprazine is a small molecule indicated for the treatment of Levodopa-induced dyskinesia.
